March 7th 2013
£670 / $1040 / €800
Drug Delivery: Surveying the global competitive landscape is a new (March 2013) richly-detailed report which examines, in depth, 106 leading and emerging specialist drug delivery companies. The report covers all major technology areas including controlled-release, nucleic acid, nano-enabled and targeted delivery.
The importance of drug-delivery technology grows ever more apparent and commercial and pharma industry interest continues to build. The new biologic products which are coming to market are widening the demand for novel delivery targeted mechanisms. Controlled-release technologies continue to play a crucial role in a product’s life-cycle and the pharma industry is able to extend patent protection and preserve revenues.
The emerging biosimilars market offers great potential for developers of targeted delivery as a range of high-value brands such as Roche’s Herceptin and Avastin will be subject to patent challenges in the coming years. With many biosimilars planned or already in development around the world, the need for novel delivery mechanisms will increase.
This report provides you with key data for each company...
The ability to readily assess the companies involved, compare areas of research interest, profile products being developed, identify strategic collaborations and evaluate performance/funding is key to understanding this market. In 716 information-packed pages, this new report Drug Delivery: Surveying the global competitive landscape (published March 2013) evaluates companies large and small from multinationals to specialist development and technology organisations.
Drug Delivery Insight
Whether your interest is commercial, financial, scientific or technological, no other business publication comes close to Drug Delivery Insight for providing such a comprehensive overview of the latest developments in every area of drug delivery. Available in print or updated regularly online.
Emerging Drug Delivery Technologies & Strategies: Players, Pipelines and Partnerships
This 3-volume 185-page report is essential for commercial business analysts, research planners and new product development specialists. Anyone who needs to understand the future outlook for, and competitive environment in, the global drug delivery market will benefit.
Drug Delivery Technologies: Advanced Oral & Parenteral
This major 2-volume report is essential reading for everyone in the drug delivery field, from niche technology specialists in the investment community and the pharmaceutical industry.
Medical Device Companies Analysis
A unique reporting service providing a complete appraisal of leading medical device companies worldwide, from 5-year financial review to analysis of significant strategic alliances and research portfolios.
This report details some of the most exciting technology out there and the companies involved
Web access included at no additional cost!